Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 174713011000036117 | carbidopa monohydrate (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 174714011000036115 | carbidopa monohydrate | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| carbidopa monohydrate | is modification of | carbidopa | true | Inferred relationship | Some | ||
| carbidopa monohydrate | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL gel: intestinal | has Australian BoSS | False | carbidopa monohydrate | Inferred relationship | Some | 123941692 |
| Duodopa gel: intestinal | has Australian BoSS | False | carbidopa monohydrate | Inferred relationship | Some | 2128680056 |
| levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | has Australian BoSS | True | carbidopa monohydrate | Inferred relationship | Some | 1679371842 |
| Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | has Australian BoSS | True | carbidopa monohydrate | Inferred relationship | Some | 1905675208 |
This concept is not in any reference sets
FHIR